Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Biopsy Versus Resection in Elderly Glioblastoma Patients. A Prospective Cohort Study.
Authors not listed
Erasmus Medical Center · 2023
Abstract
This trial is set up as a prospective observational cohort study to identify if either biopsy or resection should be the surgical modality of choice in elderly glioblastoma patients with a newly diagnosed tumor. Patients who are considered eligible for GBM resection or biopsy will be included. Through shared-decision making patients and their treating physicians will decide upon resection or biopsy. Written informed consent will be obtained. Participants will be followed for 1 year postoperative to assess potential differences in health-related quality of life and overall survival.
Follow-up will consist of health-related quality of life questionaires and neurological assessment at 6 weeks, 3 months, 6 months and 12 months postoperative. Additionally Cognitive and neuro-linguistic tests will be done at 3 months postoperative. These will be compared to results pre-operative.
After surgery, patients will receive standard adjuvant treatment with concomitant Temozolomide and radiation therapy, and standard follow-up. Patients in whom the diagnosis GBM is not confirmed in histological analyses will be excluded from the study. Total study duration will be 4 years, of which 3 years will comprise patient inclusion, with a follow-up duration of 1 year.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-11-04 MST
Cite this
APA
Anonymous. (2023). Biopsy Versus Resection in Elderly Glioblastoma Patients. A Prospective Cohort Study. <em>Erasmus Medical Center</em>. https://clinicaltrials.gov/study/NCT05641220
Vancouver
Anonymous. Biopsy Versus Resection in Elderly Glioblastoma Patients. A Prospective Cohort Study. Erasmus Medical Center. 2023.
BibTeX
@misc{anon2023Biopsy,
title = {Biopsy Versus Resection in Elderly Glioblastoma Patients. A Prospective Cohort Study.},
author = {Anonymous},
journal = {Erasmus Medical Center},
year = {2023},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Hull University Teaching Hospitals NHS Trust 2016
Open access · US-GOV
Assessment of Frailty in Elderly People With Ischemic Heart Disease Being Considered for Revascularisation.
Eisai Inc. 2016
Open access · US-GOV
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study With Open-Label Extension Phase of the Efficacy and Safety of Lemborexant in Subjects With Irregular Sleep-Wake Rhythm Disorder and Mild to Moderate Alzheimer's Disease Dementia
International Atomic Energy Agency 2009
Open access · US-GOV
A Randomized Phase III Study of Short Course (One-week) Radiation Therapy Versus Standard Course (Three-week) Radiation Therapy in Elderly and/or Frail Patients With Newly Diagnosed Glioblastoma Multiforme
Manchester University NHS Foundation Trust 2016
Open access · US-GOV
A Single-centre Prospective Study to Explore the Role of Frailty in Patients With Multiple Myeloma.
University of Sydney 2018
Open access · US-GOV
A Randomised Phase II Study of NivolUmab and TeMozolomide vs Temozolomide Alone in Newly Diagnosed Elderly Patients With Glioblastoma (NUTMEG)
Snyder, Robert W., M.D., Ph.D., P.C. 2017
Open access · US-GOV